* . *
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Monday, July 21, 2025
Earth-News
  • Home
  • Business
  • Entertainment
    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

    Kroger shares summer entertainment tips – Supermarket Perimeter

    Ultimate Summer Entertainment Tips to Make Your Season Unforgettable

    Theater at Santa Fe’s San Isidro Plaza will be converted into IMAX, family entertainment venue – Santa Fe New Mexican

    Santa Fe’s San Isidro Plaza Theater Transforms into Exciting IMAX Family Entertainment Venue

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    BlackSky Technology Inc. Stock Analysis and Forecast – Explosive wealth accumulation – Jammu Links News

    BlackSky Technology Inc.: Unlocking Explosive Wealth Potential Through Expert Stock Analysis and Forecast

    Polypurine Hairpin Technology is Safe, Effective at Inhibiting PCSK9 to Regulate Cholesterol – Pharmacy Times

    Polypurine Hairpin Technology: A Safe and Powerful Breakthrough for Controlling Cholesterol by Targeting PCSK9

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
  • Home
  • Business
  • Entertainment
    12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

    12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

    Canes owner Tom Dundon’s real estate firm eyes entertainment complex near RDU – The Business Journals

    Canes Owner Tom Dundon’s Real Estate Firm Unveils Plans for Thrilling New Entertainment Complex Near RDU

    Inspired Entertainment, Inc.’s (NASDAQ:INSE) Price Is Right But Growth Is Lacking After Shares Rocket 29% – simplywall.st

    Inspired Entertainment Soars 29% but Growth Momentum Falls Short

    Kroger shares summer entertainment tips – Supermarket Perimeter

    Ultimate Summer Entertainment Tips to Make Your Season Unforgettable

    Theater at Santa Fe’s San Isidro Plaza will be converted into IMAX, family entertainment venue – Santa Fe New Mexican

    Santa Fe’s San Isidro Plaza Theater Transforms into Exciting IMAX Family Entertainment Venue

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

    B&B Theatres will open massive entertainment complex in Texas – The Business Journals

  • General
  • Health
  • News

    Cracking the Code: Why China’s Economic Challenges Aren’t Shaking Markets, Unlike America’s” – Bloomberg

    Trump’s Narrow Window to Spread the Truth About Harris

    Trump’s Narrow Window to Spread the Truth About Harris

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    Israel-Gaza war live updates: Hamas leader Ismail Haniyeh assassinated in Iran, group says

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    PAP Boss to Niger Delta Youths, Stay Away from the Protest

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Court Restricts Protests In Lagos To Freedom, Peace Park

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Fans React to Jazz Jennings’ Inspiring Weight Loss Journey

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • Science
  • Sports
  • Technology

    Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

    Bull of the Day: Credo Technology Group (CRDO) – Yahoo Finance

    Bull of the Day: Why Credo Technology Group (CRDO) Is Poised for a Breakout

    BlackSky Technology Inc. Stock Analysis and Forecast – Explosive wealth accumulation – Jammu Links News

    BlackSky Technology Inc.: Unlocking Explosive Wealth Potential Through Expert Stock Analysis and Forecast

    Polypurine Hairpin Technology is Safe, Effective at Inhibiting PCSK9 to Regulate Cholesterol – Pharmacy Times

    Polypurine Hairpin Technology: A Safe and Powerful Breakthrough for Controlling Cholesterol by Targeting PCSK9

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    A major AI training data set contains millions of examples of personal data – MIT Technology Review

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Simpson College to purchase medical simulation technology with grant funds – Iowa Capital Dispatch

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
No Result
View All Result
Earth-News
No Result
View All Result
Home Health

Long-Acting Injectable Cabotegravir/Rilpivirine for HIV

October 30, 2023
in Health
Long-Acting Injectable Cabotegravir/Rilpivirine for HIV
Share on FacebookShare on Twitter

MedPage Today brought together three expert leaders for a virtual roundtable discussion on HIV news from the IDWeek annual meeting: Moderator Monica Gandhi, MD, MPH, of the University of California San Francisco, is joined by Kathleen A. McManus, MD, of the University of Virginia School of Medicine in Charlottesville, and Laura Bamford, MD, of the University of California San Diego School of Medicine.

This first of four exclusive episodes examines data from the OPERA cohort on cabotegravir-rilpivirine (Cabenuva) as well as its effect on hepatitis B patients who switched to the therapy.

Following is a transcript of their remarks:

Gandhi: Hi, my name is Dr. Monica Gandhi, I’m a professor of medicine and the medical director of the Ward 86 HIV clinic at UCSF. And I’m really excited to talk about the HIV news out of IDWeek for MedPage today. And Dr. Bamford, you’re joining me, please tell us about yourself.

Bamford: Thank you, Dr. Gandhi. I’m Laura Bamford. I’m an associate professor in the Division of Infectious Diseases and Global Public Health at UC San Diego and also the medical director of the HIV Medicine Clinic here, the Owen Clinic. Dr. McManus?

McManus: Hi, I’m Kate McManus. I’m an assistant professor at the University of Virginia and the medical director of the University of Virginia Ryan White Clinic.

Gandhi: So there were some really interesting things out of IDWeek, I thought. And I think if we want to divide them, we could think about dividing them into the long-acting injectables, which there’s just more and more data on. There were effects of weight and hepatitis B and then some on PrEP.

And to start with the long-acting, there hasn’t been a lot of data out there about using long-acting injectables in viremic patients or participants. There was a small University of Mississippi study published over the summer in CID [Clinical Infectious Diseases], and our clinic, Ward 86, has done some work looking at long-acting cabotegravir and rilpivirine in viremic patients.

But this was nice to see at this meeting the OPERA study, which is really a large retrospective cohort study of patients in care across the U.S. Actually I believe 14% of patients living with HIV are represented in the OPERA cohort. And because now long-acting cabotegravir and rilpivirine has been out for 2 years more, there’s certainly providers out there who are trying the use of these medications in patients who start with viremia and cannot take oral ART [antiretroviral therapy].

And so there were kind of two abstracts at the meeting that discussed this, but I think the most notable one was really looking at those in the OPERA cohort who had started with a viral load of greater than 50 and of those patients 50 copies/mL and there were 229 of those patients. So they started with greater than 50 copies/mL, got put on long-acting cabotegravir-rilpivirine and their viral load, if we had enough measurements essentially, their viral load was suppressed less than 50, 82% of the time and less than 200, 94% of the time. So it kind of mirrors what we’ve seen in these other smaller cohorts that does look like it works in patients with viremia.

I wonder what you thought about that? It was the largest kind of database to add to this question.

McManus: I think it’s great to see this from different angles to see it from your clinic, now to see it in this retrospective look. I think it just adds more evidence and more data that hopefully we’re going to be able to do this more widely through more clinics.

Gandhi: Yeah, I think this is going to give it a boost, this question of using it in viremics. And I have to say, I don’t know if you all saw Dr. [Paul] Sax’s NEJM Journal Watch commentary that he put out on September 25, 2023, but he said, if you can’t take oral ART, there is a role for long-acting even with the small studies we have. And he wrote about that prior to the OPERA analysis. So I think that’s just going to get more credence to, is this going to ever be in the guidelines as a, again, only if you can’t take oral ART, but if you can’t take oral ART, your chances of success is zero. So I think this was intriguing retrospective data.

There were also some comorbidity data, Laura, and I was wondering what you thought about that with the hepatitis B? Because one thing I will tell you is that we have been trying to be really careful when we switch patients to cabotegravir-rilpivirine about reminding ourselves about patient’s hepatitis B status and really tracking that because of course cabotegravir-rilpivirine don’t work against hepatitis B.

Bamford: No, that’s a very good segue. So this a study that was presented at IDWeek from a VA cohort of patients who did exactly that, switched off a regimen that included hepatitis B treatment mostly to cabotegravir and rilpivirine. And while reactivation was rare in this cohort, it wasn’t zero, about 1.5%, but this was also performed in the U.S., which we don’t think of as an endemic area for hepatitis B. Reactivation was more common in participants who were core antibody alone, so probably those that either lost surface antibody over time or their surface antigen was now at undetectable levels. So in participants that were HepB surface antibody and core antibody, even lower levels of reactivation, but also not zero.

And so I think, like you said, Dr. Gandhi, we need to be very careful in switching patients and really I think discussing with them with shared decision-making, are patients willing to take that risk to come off of an all oral regimen.

McManus: Yeah, I think this was a great study, because this is definitely something we come across in the clinic, either seeing patients who maybe other clinics switched off of HepB active therapy and wondering, wow, did they just get lucky? Or this person didn’t reactivate, what should we do now? So I think this definitely gives us kind of a number to talk to patients with that shared decision-making.

And then I think even the team pointed out, the team that did this study, that a previous study showed a reactivation rate of 10% in Cameroon. And so kind of knowing that it might span somewhere from the 1.5-10% depending on different areas or different sorts of other circumstances.

Gandhi: Yes. I mean, sorry, I was just going to say that we have tried to pay attention to it, but if we don’t do a recent hepatitis B core antibody surface antibody surface antigen, we may have made assumptions that the surface antibody is still positive and that the patient is immune. And so now we’re pretty rigorous when we use cabotegravir and rilpivirine to repeat those serologies and to ensure that we know where they are with their current hepatitis B status.

Bamford: And I think based on this study, if we then find that someone is core antibody positive, one, checking for HepB DNA levels, but also vaccinating them for HepB and make sure they’re achieving surface antibody because that seems to lower the risk. But we can also be vigilant, but then if our patients are going to oncology or rheumatology and getting other immunosuppressive agents, we really have to remind patients that they do at that point need to go back on their hepatitis B treatment.

author['full_name']

Greg Laub is the Senior Director of Video and currently leads the video and podcast production teams. Follow

>>> Read full article>>>
Copyright for syndicated content belongs to the linked Source : MedPageToday – https://www.medpagetoday.com/meetingcoverage/idweekexpertvideoroundtable/107072

Tags: healthInjectableLong-Acting
Previous Post

It’s Never Too Soon to Start End-of-Life Conversations

Next Post

FDA Reviewers Question Safety of Sickle Cell Gene Therapy

Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

July 21, 2025
Fanatics aided criminal investigation into sports memorabilia dealer. The dealer was later found dead. – The Athletic – The New York Times

Fanatics Helped Crack Sports Memorabilia Case Before Dealer’s Mysterious Death

July 21, 2025
Architecture Students’ Project Selected for Royal Academy Exhibition – Syracuse University News

Syracuse Architecture Students Selected for Prestigious Royal Academy Exhibition

July 21, 2025
Health experts raise alarm over RFK Jr’s ‘war on science’ amid mass firings and budget cuts – The Guardian

Health Experts Sound the Alarm on RFK Jr’s ‘War on Science’ Amid Mass Firings and Budget Cuts

July 21, 2025
Do dogs know who’s kind? Scientists put it to the test—and got a surprise – ScienceDaily

Do dogs know who’s kind? Scientists put it to the test—and got a surprise – ScienceDaily

July 21, 2025
Making these lifestyle changes reduces chronic disease, even if you have a genetic risk – WPBF

Transform Your Health: Simple Lifestyle Changes That Slash Chronic Disease Risk-Even If It Runs in Your Genes

July 21, 2025
Win a VIP trip to Tokyo – worldathletics.org

Win an Exclusive VIP Trip to Tokyo – Enter Now for Your Chance!

July 21, 2025
Under Governor Shapiro, Pennsylvania is a National Leader in Economic Growth, AI Innovation, and Energy – PA Department of Community & Economic Development (.gov)

Under Governor Shapiro, Pennsylvania is a National Leader in Economic Growth, AI Innovation, and Energy – PA Department of Community & Economic Development (.gov)

July 21, 2025
12 ‘Late Show’ Moments Proving Stephen Colbert Can’t Be Replaced – The Mountaineer

12 Unforgettable ‘Late Show’ Moments That Prove Stephen Colbert Is Truly One of a Kind

July 21, 2025
AI in health care could save lives and money — but not yet – PBS

AI in health care could save lives and money — but not yet – PBS

July 21, 2025

Categories

Archives

July 2025
MTWTFSS
 123456
78910111213
14151617181920
21222324252627
28293031 
« Jun    
Earth-News.info

The Earth News is an independent English-language daily published Website from all around the World News

Browse by Category

  • Business (20,132)
  • Ecology (731)
  • Economy (754)
  • Entertainment (21,639)
  • General (16,014)
  • Health (9,792)
  • Lifestyle (762)
  • News (22,149)
  • People (756)
  • Politics (763)
  • Science (15,971)
  • Sports (21,252)
  • Technology (15,737)
  • World (737)

Recent News

Defence Holdings PLC Transitions from Esports to Pioneering Defence Technology

July 21, 2025
Fanatics aided criminal investigation into sports memorabilia dealer. The dealer was later found dead. – The Athletic – The New York Times

Fanatics Helped Crack Sports Memorabilia Case Before Dealer’s Mysterious Death

July 21, 2025
  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

No Result
View All Result

© 2023 earth-news.info

Go to mobile version